Argen X SE ADR (ARGX): Next-Year EPS Estimate 35.84%
As of 2026-06-04, Argen X SE ADR (ARGX) has a next-year EPS growth estimate of 35.84%.
ARGX was first flagged by our screen on 2026-05-31, when analyst consensus for its next-year EPS growth was revised from 35.79% to 35.82%. Since detection, the estimate has climbed steadily to 35.84% — a net gain of 0.02 percentage points across 2 upward revisions. Current-year growth is projected at 36.11%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 35.84%
- EPS growth this year
- 36.11%
- EPS next quarter (est)
- $6.28
- Last price
- $842.27
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 35.84% | 36.11% | $6.28 | $842.27 |
| 2026-06-03 | 35.83% | 36.62% | $6.34 | $813.14 |
| 2026-06-02 | 35.83% | 36.62% | $6.34 | $802.17 |
| 2026-06-01 | 35.82% | 36.63% | $6.34 | $836.09 |
| 2026-05-31 | 35.82% | 36.63% | $6.34 | $835.99 |
| 2026-05-28 | 35.79% | 36.63% | $6.34 | $838.49 |
| 2026-05-27 | 35.79% | 36.63% | $6.34 | $820.63 |
| 2026-05-26 | 35.44% | 37.22% | $6.38 | $808.43 |
| 2026-05-25 | 35.44% | 37.22% | $6.38 | $806.46 |
| 2026-05-24 | 35.44% | 37.22% | $6.38 | $806.46 |
| 2026-05-21 | 35.44% | 37.22% | $6.38 | $816.22 |
| 2026-05-20 | 35.44% | 37.22% | $6.38 | $804.25 |
| 2026-05-19 | 35.44% | 37.22% | $6.38 | $797.77 |
| 2026-05-18 | 35.44% | 37.22% | $6.38 | $776.26 |
| 2026-05-17 | 35.44% | 37.22% | $6.38 | $799.32 |
| 2026-05-14 | 35.48% | 37.06% | $6.38 | $822.13 |
| 2026-05-13 | 35.60% | 37.32% | $6.38 | $790.56 |
| 2026-05-12 | 35.60% | 37.32% | $6.38 | $812.81 |
| 2026-05-11 | 35.63% | 37.31% | $6.38 | $813.28 |
| 2026-05-10 | 35.43% | 37.67% | $6.38 | $782.17 |
| 2026-05-07 | 31.69% | 34.81% | $6.06 | $787.31 |
| 2026-05-06 | 31.40% | 34.32% | $5.38 | $807.55 |
| 2026-05-05 | 31.40% | 34.32% | $5.38 | $794.70 |
| 2026-05-04 | 31.40% | 34.32% | $5.38 | $811.09 |
| 2026-05-03 | 31.40% | 34.32% | $5.38 | $783.50 |
| 2026-04-30 | 31.40% | 34.32% | $5.38 | $781.72 |
| 2026-04-29 | 31.40% | 34.32% | $5.38 | $776.02 |
| 2026-04-28 | 31.40% | 34.32% | $5.38 | $775.03 |
| 2026-04-27 | 31.40% | 34.32% | $5.38 | $783.74 |
| 2026-04-26 | 31.40% | 34.32% | $5.38 | $780.25 |
Recent News
- argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMGGlobeNewswire
- FDA to reevaluate spurned cell therapy; Under-the-skin Leqembi review extendedBioPharma Dive
- Argenx Obliterates Profit Expectations On 'Solid Print' For Its Immunology PowerhouseInvestor's Business Daily
- Argenx (ARGX) tops earnings expectations despite slight revenue shortfallInvestorsHub
- argenx Reports First Quarter 2026 Financial Results and Provides Business UpdateGlobeNewswire
- argenx to Present at BofA Securities 2026 Health Care ConferenceGlobeNewswire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Argen X SE ADR's next-year EPS growth estimate?▾
As of 2026-06-04, Argen X SE ADR (ARGX) has a next-year EPS growth estimate of 35.84%, based on analyst consensus.
When was the latest EPS estimate revision for ARGX?▾
The most recent revision occurred on 2026-06-04, when analysts adjusted the next-year EPS growth estimate from 35.83% to 35.84%.
What sector and industry does Argen X SE ADR belong to?▾
Argen X SE ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ARGX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Argen X SE ADR (ARGX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports